Gain Therapeutics (GANX) Current Taxes (2020 - 2025)
Historic Current Taxes for Gain Therapeutics (GANX) over the last 6 years, with Q3 2025 value amounting to $46289.0.
- Gain Therapeutics' Current Taxes rose 12041.33% to $46289.0 in Q3 2025 from the same period last year, while for Sep 2025 it was $46289.0, marking a year-over-year increase of 12041.33%. This contributed to the annual value of $18493.0 for FY2024, which is 6223.22% down from last year.
- Gain Therapeutics' Current Taxes amounted to $46289.0 in Q3 2025, which was up 12041.33% from $25169.0 recorded in Q2 2025.
- Gain Therapeutics' Current Taxes' 5-year high stood at $184693.0 during Q2 2023, with a 5-year trough of $380.0 in Q4 2021.
- For the 5-year period, Gain Therapeutics' Current Taxes averaged around $43763.7, with its median value being $21001.0 (2024).
- In the last 5 years, Gain Therapeutics' Current Taxes skyrocketed by 2813973.68% in 2022 and then plummeted by 7593.33% in 2025.
- Over the past 5 years, Gain Therapeutics' Current Taxes (Quarter) stood at $380.0 in 2021, then surged by 28139.74% to $107311.0 in 2022, then tumbled by 54.37% to $48965.0 in 2023, then crashed by 62.23% to $18493.0 in 2024, then soared by 150.31% to $46289.0 in 2025.
- Its last three reported values are $46289.0 in Q3 2025, $25169.0 for Q2 2025, and $17973.0 during Q1 2025.